about
THE ROLE OF CYSTEINE PROTEASE IN ALZHEIMER DISEASEA call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive declineCognitive impairment and stroke in elderly patientsInteraction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsThe dendritic hypothesis for Alzheimer's disease pathophysiology.Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal StudiesPotential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia.Hydrogen Sulfide Prevents Synaptic Plasticity from VD-Induced Damage via Akt/GSK-3β Pathway and Notch Signaling Pathway in Rats.A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patientsThe Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.N-Butylphthalide Improves Cognitive Function in Rats after Carbon Monoxide Poisoning.Calcium channel blockers in cardiovascular pharmacotherapy.Control of translation in the cold: implications for therapeutic hypothermia.Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).Amlodipine treatment of hypertension associates with a decreased dementia risk.Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.Danger: High Voltage-The Role of Voltage-Gated Calcium Channels in Central Nervous System Pathology.Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs.Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.Pharmacotherapy for Vascular Cognitive Impairment.Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's diseaseSTIM1 deficiency is linked to Alzheimer's disease and triggers cell death in SH-SY5Y cells by upregulation of L-type voltage-operated Ca entry
P2860
Q26740104-19EDC9FE-3EC8-45F3-8B12-CE578D61460DQ26740260-D9286700-CF9E-4F6E-9DBE-F6901527BBACQ26749183-1B0814CB-B8F9-49C0-BBD0-877CFE4ABD0AQ27001177-DBF69EF6-5877-476A-88F7-DCD557E139C7Q27687404-3CCD9F33-AE85-409F-AAB7-9B7BAF1844DAQ28074637-DD6114EC-1968-4988-A1E3-E600CAF9ADDFQ35780850-F7131A38-EDB8-4CAA-9907-EAF74B392FE6Q36057329-1A7A9AF0-874E-427F-8D04-AF63884438AAQ37075664-92BC81C0-EEAF-4E47-AEF0-8812F21DB984Q37176098-57BFDF03-E9F0-4090-A2A8-706360E3202CQ37502130-33DCAB47-14C3-4E1A-9D8C-07034C935D25Q37632936-6DB8F6E9-07C2-4F51-99DF-98A239EE1E36Q38215726-8C41D937-F9D0-4A26-BFE4-24AA2467BB7EQ38502021-4A505BC2-DACA-4DF2-948C-18F2DA52BA73Q39038234-7FB0851E-ADF0-4AC9-9462-9EB3A903C44BQ40661217-525FB9FF-3AEB-4587-931B-64937529431FQ41527014-BF194C0A-D5AF-4437-96F2-FBD1BA1D9CCDQ47838572-8B8C5F04-1189-4F4C-918E-75A1D048291AQ50326656-838883C3-9E1B-4D42-9C74-8D0E329DCF06Q50556631-BADA4AD7-A941-4635-988F-27010C86A97DQ54440823-708780B3-7D46-492B-837A-D16EE0587FB2Q58566954-79B5CCA6-18EA-488A-9EA9-E1DE34B02618Q58796720-78BB3E7C-1472-4704-BA9D-F4A9CB4C3041
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Calcium channel blockers and dementia.
@en
type
label
Calcium channel blockers and dementia.
@en
prefLabel
Calcium channel blockers and dementia.
@en
P2860
P356
P1476
Calcium channel blockers and dementia.
@en
P2093
P2860
P304
P356
10.1111/BPH.12240
P407
P577
2013-07-01T00:00:00Z